Skip to content

Bio-Rad Laboratories, Inc. BIO.B All Other Segments — Net Sales

Other segment segments

Clinical Diagnostics
$363.6M+1.9%
Life Science
$228.5M0.0%

Similar metrics at other companies

TEC
TECHAll Other Segments — Other Revenues Excluding Amounts Attributable To Assets Held For Sale Net
$5.44M+136%
Cognizant logo
CTSHAll Other Segments — Net Revenue
$350.43M+17.4%
Sanmina Corp logo
SANMAll Other Segments — Revenue
$399.6M-8.6%
Labcorp Holdings logo
LHAll Other Segments — Net Revenue
$759.3M+6.8%
Albemarle logo
ALBAll Other — Net Sales
$0
Hormel Foods logo
HRLAll Other Segments — Net Revenue
$147.59M+11.1%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: Bio-Rad Laboratories, Inc.’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s all other segments — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s all other segments — net sales?
Bio-Rad Laboratories, Inc. (BIO.B) reported all other segments — net sales of $0 in Q4 2025.
How has Bio-Rad Laboratories, Inc.'s all other segments — net sales changed year-over-year?
Bio-Rad Laboratories, Inc.'s all other segments — net sales decreased by 100.0% year-over-year, from $125K to $0.
What is the long-term trend for Bio-Rad Laboratories, Inc.'s all other segments — net sales?
Over 3 years (2022 to 2025), Bio-Rad Laboratories, Inc.'s all other segments — net sales has grown at a -100.0% compound annual growth rate (CAGR), from $4M to $0.
What does all other segments — net sales mean?
Total revenue generated by the company's miscellaneous or non-core business segments.
How do you interpret all other segments — net sales?
An increase indicates growth in non-core business areas, while a decrease suggests divestiture or declining interest in these secondary activities.
How does all other segments — net sales compare across companies?
Peers often report similar 'Other' segments for non-core operations, though the composition varies significantly by company.